sacituzumab
gilead
['sacituzumab', 'breast', 'tropics-02', 'sacitu, govi', 'trodelvy', 'gilead']
gilead to presents p-iii (tropics-02) study results of trodelvy (sacituzumab govitecan) for pre-treated hr+/her2- metastatic breast cancer at asco 2023 #clinicaltrials 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds